Abstract
Objectives. To measure rates of intimate partner violence (IPV) screening during the perinatal period among people experiencing physical violence in the United States. Methods. We used 2016–2019 Pregnancy Risk Assessment Monitoring System data (n 5 158 338) to describe the incidence of physical IPV before or during pregnancy. We then assessed the prevalence of IPV screening before, during, or after pregnancy and predictors of receiving screening among those reporting violence. Results. Among the 3.5% (n 5 6259) of respondents experiencing violence, 58.7%, 26.9%, and 48.3% were not screened before, during, or after pregnancy, respectively. Those reporting Medicaid or no insurance at birth, American Indian/Alaska Native people, and Spanish-speaking Hispanic people faced increased risk of not having a health care visit during which screening might occur. Among those attending a health care visit, privately insured people, rural residents, and non-Hispanic White respondents faced increased risk of not being screened. Conclusions. Among birthing people reporting physical IPV, nearly half were not screened for IPV before or after pregnancy. Public health efforts to improve maternal health must address both access to care and universal screening for IPV.
Original language | English (US) |
---|---|
Pages (from-to) | 297-305 |
Number of pages | 9 |
Journal | American journal of public health |
Volume | 113 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2023 |
Bibliographical note
Funding Information:This research was supported in part by the National Institutes of Health (NIH), National Center for Advancing Translational Sciences (grant UL1TR002494). L. Admon is supported by the Agency for Healthcare Research and Quality (grant K08HS027640) and the NIH (grants R01MH120124 and R01MD014958).
Funding Information:
This research was supported in part by the National Institutes of Health (NIH), National Center for Advancing Translational Sciences (grant UL1TR002494). L. Admon is supported by the Agency for Healthcare Research and Quality (grant K08HS027640) and the NIH (grants R01MH120124 and R01MD014958). The authors gratefully acknowledge all Pregnancy Risk Surveillance and Monitoring System (PRAMS) study participants and members of the PRAMS Working Group at the Centers for Disease Control and Prevention. The authors also thank Alyssa H. Fritz, MPH, RD, for helpful input on the article. Note. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality or the NIH.
Publisher Copyright:
© 2023 Authors. All rights reserved.
PubMed: MeSH publication types
- Journal Article
- Research Support, N.I.H., Extramural